financetom
Business
financetom
/
Business
/
MTY Foods Q1 Adjusted Earnings, Revenue Beat Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MTY Foods Q1 Adjusted Earnings, Revenue Beat Estimates
Apr 11, 2025 4:44 AM

07:20 AM EDT, 04/11/2025 (MT Newswires) -- MTY Foods (MTY.TO) on Friday reported higher first-quarter earnings and revenue that beat estimates.

Net earnings per diluted share, adjusted for one most one-time items rose to $0.87, from $0.69 in the prior year period. The result beat the consensus analyst estimate of $0.85, according to Capital IQ.

Revenue increased to $285 million, from $279 million, beating the $275.6 million forecast. The increase was driven by strong performance in the corporate segment, both in Canada and the US. Favourable foreign exchange also helped boost system sales by 2.5% to $1.36 billion, the company said.

Same-store sales decreased 1.5% in the first quarter, due to the fact that the 2024 leap year added an extra sales day.

"Our same-store sales held relatively stable, once adjusted for the leap year impact - demonstrating the strength and resilience of our portfolio," said Chief Executive Eric Lefebvre. "While adverse weather conditions temporarily pressured performance, particularly in our US frozen treats segment, the start of Q2 signals a return to more normal operating conditions. Canada continues to perform consistently, underscoring the stability of our operations."

MTY Foods will pay a quarterly dividend of $0.33 per share on May 15.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Natera Insider Sold Shares Worth $2,269,928, According to a Recent SEC Filing
Natera Insider Sold Shares Worth $2,269,928, According to a Recent SEC Filing
Feb 3, 2025
03:09 AM EST, 02/03/2025 (MT Newswires) -- Steven Leonard Chapman, Director, Chief Executive Officer and President, on January 29, 2025, sold 13,685 common shares in Natera ( NTRA ) for $2,269,928. Following the Form 4 filing with the SEC, Chapman has control over a total of 253,944 shares of the company, with 253,944 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1604821/000141588925002621/xslF345X05/form4-01312025_090101.xml ...
Tempus AI Insider Sold Shares Worth $13,278,632, According to a Recent SEC Filing
Tempus AI Insider Sold Shares Worth $13,278,632, According to a Recent SEC Filing
Feb 3, 2025
03:10 AM EST, 02/03/2025 (MT Newswires) -- Eric P Lefkofsky, 10% Owner, Director, Chief Executive Officer and Chairman, on January 29, 2025, sold 238,800 Class A common shares in Tempus AI ( TEM ) for $13,278,632. Following the Form 4 filing with the SEC, Lefkofsky has control over a total of 48,757,318 shares of the company, with 5,532,987 shares held...
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
Feb 3, 2025
03:12 AM EST, 02/03/2025 (MT Newswires) -- Craig C. Hopkinson, Executive Vice President, Research & Development, Chief Medical Officer, on January 30, 2025, sold 100,918 ordinary shares in Alkermes ( ALKS ) for $3,234,382. Following the Form 4 filing with the SEC, Hopkinson has control over a total of 44,290 shares of the company, with 44,290 shares held directly. SEC...
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
Feb 3, 2025
ROME (Reuters) - EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its over-the-counter Nuance audio glasses. Nuance - which pairs hearing solutions with prescription glasses - will be available in the U.S. and in Italy in the first quarter of the year and in other European countries, including France, Germany...
Copyright 2023-2025 - www.financetom.com All Rights Reserved